ask="12.30"
ask_size="1000"
average_daily_volume="26560"
bid="N/A"
bid_size="N/A"
book_value="3.34"
change="-0.03"
change_from_200_day_moving_average="4.09"
change_from_50_day_moving_average="2.63"
change_from_52_week_high="-0.21"
change_From_52_week_low="7.27"
change_in_percent="-0.28%"
close="10.79"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-2.26"
ebitda="-50.28M"
eps_estimate_current_year="-2.54"
eps_estimate_next_quarter="-0.60"
eps_estimate_next_year="-2.57"
ex_dividend_date="N/A"
float_shares="N/A"
high="10.90"
high_52_weeks="11.00"
last_trade_date="2/21/2017"
last_trade_price="10.79"
last_trade_size="201"
last_trade_time="4:00pm"
low="10.51"
low_52_weeks="3.52"
market_capitalization="229.61M"
moving_average_200_day="6.70"
moving_average_50_day="8.16"
name="Nabriva Therapeutics AG"
notes="N/A"
one_year_target_price="15.83"
open="10.85"
pe_ratio="N/A"
peg_ratio="0.00"
percent_change_from_200_day_moving_average="+61.00%"
percent_change_from_50_day_moving_average="+32.25%"
percent_change_from_52_week_high="-1.91%"
percent_change_from_52_week_low="+206.53%"
previous_close="10.82"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="3.24"
price_per_sales="44.28"
revenue="5.20M"
shares_outstanding="21280000"
short_ratio="3.79"
stock_exchange="NMS"
symbol="NBRV"
volume="24879"
weeks_range_52="3.52 - 11.00"
